Angelo Ranieri

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli et al. · The Journal of Headache and Pain · 2021 · 150 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study

Piero Barbanti, Gabriella Egeo, Cinzia Aurilia et al. · The Journal of Headache and Pain · 2023 · 60 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study

Raffaele Ornello, Carlo Baraldi, Simona Guérzoni et al. · The Journal of Headache and Pain · 2022 · 48 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing - Remitting Multiple Sclerosis

Giorgia Teresa Maniscalco, Mario Annunziata, Angelo Ranieri et al. · Multiple Sclerosis and Related Disorders · 2020 · 46 citations

Life Sciences, Immunology, Neurology +16

Narrative Medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project

Maria Clara Tonini, Alessandra Fiorencis, Rosario Iannacchero et al. · Neurological Sciences · 2021 · 32 citations · Full text

Medicine, Neurology, Psychiatry +15